We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VDE icon
2726
Vanguard Energy ETF
VDE
$9.9B
$530K ﹤0.01%
+4,953
New +$477K
WWW icon
2727
Wolverine World Wide
WWW
$1.68B
$530K ﹤0.01%
23,497
-166,461
-88% -$4.15M
AAT
2728
American Assets Trust
AAT
$1.45B
$529K ﹤0.01%
13,954
-24,881
-64% -$912K
PPTA
2729
Perpetua Resources
PPTA
$2.13B
$528K ﹤0.01%
128,573
+36,915
+40% +$148K
VMD icon
2730
Viemed Healthcare
VMD
$454M
$525K ﹤0.01%
+105,492
New +$490K
ITRI icon
2731
Itron
ITRI
$4.49B
$523K ﹤0.01%
+9,938
New +$556K
NKGN
2732
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
$523K ﹤0.01%
54,089
REI icon
2733
Ring Energy
REI
$312M
$520K ﹤0.01%
+136,263
New +$418K
BMTX
2734
DELISTED
BM Technologies, Inc.
BMTX
$518K ﹤0.01%
60,573
-22,812
-27% -$211K
CALT
2735
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$518K ﹤0.01%
27,910
-52,763
-65% -$1.06M
FORG
2736
DELISTED
ForgeRock, Inc.
FORG
$515K ﹤0.01%
+23,428
New +$396K
SMLR
2737
DELISTED
Semler Scientific
SMLR
$512K ﹤0.01%
10,309
+7,472
+263% +$501K
AIRC
2738
DELISTED
Apartment Income REIT Corp.
AIRC
$510K ﹤0.01%
9,557
+9,501
+16,966% +$501K
BRBS icon
2739
Blue Ridge Bankshares
BRBS
$315M
$509K ﹤0.01%
+33,527
New +$561K
VENAW
2740
CALL
DELISTED
Venus Acquisition Corporation Warrant
VENAW
$508K ﹤0.01%
50,000
ARCB icon
2741
ArcBest
ARCB
$3.12B
$507K ﹤0.01%
6,296
-6,191
-50% -$558K
YI
2742
111 Inc
YI
$33.4M
$505K ﹤0.01%
18,985
+5,437
+40% +$158K
DFLIW icon
2743
CALL
Dragonfly Energy Holdings Warrant
DFLIW
$51.4K
$504K ﹤0.01%
50,000
HSIC icon
2744
Henry Schein
HSIC
$9.72B
$503K ﹤0.01%
5,775
-109,019
-95% -$8.88M
REFI
2745
Chicago Atlantic Real Estate Finance
REFI
$254M
$503K ﹤0.01%
+28,354
New +$525K
BNED icon
2746
Barnes & Noble Education
BNED
$441M
$502K ﹤0.01%
+1,401
New +$748K
RNW icon
2747
ReNew
RNW
$2.18B
$501K ﹤0.01%
61,054
+37,557
+160% +$272K
HTAQ.WS
2748
CALL
DELISTED
Hunt Companies Acquisition Corp. I Warrants, each exercisable for one Class A ordinary share at an exercise price of $11.50 per share
HTAQ.WS
$501K ﹤0.01%
+49,999
New +$16.3K
MA icon
2749
CALL
Mastercard
MA
$502B
$500K ﹤0.01%
1,400
-10,800
-89% -$3.88M
AGEN
2750
Agenus
AGEN
$277M
$499K ﹤0.01%
+10,337
New +$559K

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.